In 2013, the FDA announced a potential safety issue for mothers taking Zofran, though was careful to note that, listing of a drug and a potential safety issue does not mean that FDA is suggesting prescribers should not prescribe the drug or that patients taking the drug should stop taking the medication. It is unknown whether Zofran transfers into breast milk
Your healthcare provider must know the full context: the reason for steroid use, the planned duration, the specific steroid and its dose, and your baseline glucose control
Most seizures last from 30 seconds to two minutes
Nutrafol has fast become the fastest-growing supplement for healthy hair and hair growth
Research Use Only This product is intended strictly for laboratory research purposes
In 2023, Pfizer published research papers successively, reporting the results of randomized clinical trials on the efficacy and safety of PF-06882961 for blood sugar control in patients with type 2 diabetes, the safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06882961 in Japanese adults with type 2 diabetes from a phase 1 clinical trial, and the results of a 12-week randomized, placebo-controlled, dose-escalation phase 2 trial on the tolerability, safety, and pharmacodynamics of PF-06882961 for the treatment of type 2 diabetes